The FDA has allowed marketing of the first nucleic acid test that can identify 12 different bacterial types known to cause bloodstream infections.
The Verigene GP Blood Culture Nucleic Acid Test can identify different types of Staphylococcus, Streptococcus, Enterococcus and Listeria in just a few hours after the first sign of bacterial growth.
The FDA based its decision on a study of 1,642 patient blood samples obtained from incubated blood culture bottles that contained gram positive bacteria. The study included a comparison of the Verigene test and traditional blood culture laboratory methods. The Verigene results were consistent with traditional blood culture methods in 93 percent to 100 percent of the comparisons.
Sign up for our FREE E-Weekly for more coverage like this sent to your inbox!
The Verigene GP Blood Culture Nucleic Acid Test can identify different types of Staphylococcus, Streptococcus, Enterococcus and Listeria in just a few hours after the first sign of bacterial growth.
The FDA based its decision on a study of 1,642 patient blood samples obtained from incubated blood culture bottles that contained gram positive bacteria. The study included a comparison of the Verigene test and traditional blood culture laboratory methods. The Verigene results were consistent with traditional blood culture methods in 93 percent to 100 percent of the comparisons.
More Articles on Bloodstream Infections:
NHSN May Be Superior Method of Measuring Healthcare-Associated Infections
Oregon Sees Sharp Decrease in Healthcare-Acquired Infections
12 Hospitals Awarded for Eliminating Healthcare-Associated Infections
